Skip to main content
Log in

Recurrent angioedema: diagnosis strategy and biological aspects

  • Review article
  • Published:
European Journal of Dermatology Aims and scope

Abstract

The aetiologies of recurrent angioedema (AE) comprise the frequent histaminergic AE and the rare bradykinin-mediated AE. Diagnosis must be done carefully because they do not have the same treatment. Diagnosis strategy is clinical. The most specific symptoms for bradykinin AE are: isolated AE without wheals, long duration of the attack, abdominal localisation. The unique useful biological tests for the diagnosis of bradykinin AE are C1Inh exploration which is altered in hereditary AE (HAE) types I and II. No other biological test is useful in clinical practice at present. In case of suspicion of bradykinin AE with normal C1Inh, physicians must think of drug-induced AE. Hereditary AE with normal C1Inh may be associated with a mutation on gene F12 in 20% of cases. For 80% of patients without mutation, the diagnosis must be done very carefully.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Grattan C, Powell S, Humphreys F. Management and diagnostic guidelines for urticaria and angio-oedema. Br J Dermatol 2001; 144: 708–14.

    Article  CAS  PubMed  Google Scholar 

  2. Kaplan AP, Greavs MW. Angioedema. J Am Acad Dermatol 2005; 53: 373–88.

    Article  PubMed  Google Scholar 

  3. Zingale L, Beltrami L, Zanichelli A, et al. Angioedema without urticaria: a large clinical survey. CMAJ 2006; 175: 1065–70.

    Article  PubMed Central  PubMed  Google Scholar 

  4. Kulthanan K, Jiamton S, Boochangkool K, Jongjarearnprasert K. Angioedema: Clinical and Etiological Aspects. Clin Dev Immunol 2007; 2007: 26438.

    Article  PubMed Central  PubMed  Google Scholar 

  5. Bouillet L, Boccon-Gibod I, Massot C. Bradykinin mediated angioedema. Rev Med Intern 2011; 32: 225–31.

    Article  CAS  Google Scholar 

  6. Boccon-Gibod I. Urticaire/angioedème histaminique ou bradykinique. Rev Fr Allergol 2012; 52: 327–32.

    Article  Google Scholar 

  7. Longhurst H, Cicardi M. Hereditary angioedema. Lancet 2012; 379: 474–81.

    Article  PubMed  Google Scholar 

  8. Augey F, Nosbaum A, Berard F, Nicolas JF. Corticosteroids should not be used in urticaria because of the potential risk of steroid dependence and development of severe anti-H1-resistant urticaria. Eur J Dermatol. 2011; 21: 431.

    PubMed  Google Scholar 

  9. Zuberbier T, Asero R, Bindslev-Jensen C, et al. EAACI/GA2LEN/EDF/WAO guideline: management of urticaria. Allergy 2009; 64: 1427–43.

    Article  CAS  PubMed  Google Scholar 

  10. Bork K, Meng G, Staubach P, Hardt J. Hereditary Angioedema: New Findings concerning Symptoms, Affected Organs, and Course. Am J Med 2006; 119: 267–74.

    Article  PubMed  Google Scholar 

  11. Agostoni A, Cicardi M. Drug-induced angioedema without urticaria. Drug Saf 2001; 24: 599–606.

    Article  CAS  PubMed  Google Scholar 

  12. Beltrami L, Zanichelli A, Zingale L, Vacchinib R, Carugo S, Cicardi M. Long-term follow-up of 111 patients with angiotensin converting enzyme inhibitor-related angioedema. J Hypertens 2011; 29: 2273–7.

    Article  CAS  PubMed  Google Scholar 

  13. Consensus HAS urticaire chronique 2003: http://www.hassante.fr/portail/upload/docs/application/pdf/urticaire_court.pdf

  14. Cugno M, Nussberger J, Cicardi M, Agostini A. Bradykinin and the physiopathology of angioedema. Int Imunopharmacol 2003; 3: 311–7.

    Article  CAS  Google Scholar 

  15. Vitrat-Hincky V, Gompel A, Dumestre-Perard C, et al. Type III hereditary angio-oedema: clinical and biological features in a French cohort. Allergy 2010; 65: 1331–6.

    Article  CAS  PubMed  Google Scholar 

  16. Bowen T, Cicardi M, Farkas H, et al. 2010 International consensus algorithm for the diagnosis, therapy and management of hereditary angioedema. Allergy Asthma Clin Immunol 2010; 6: 24–37.

    Article  PubMed Central  PubMed  Google Scholar 

  17. Longhurst H, Cicardi M. Hereditary angio-oedema Lancet 2012; 379: 474–81.

    Google Scholar 

  18. Gordon EM, Ratnoff OD, Saito H, Donaldson VH, Pensky J, Jones PK. Rapid fibrinolysis, augmented Hageman factor (factor XII) titers, and decreased C1 esterase inhibitor titers in women taking oral contraceptives. J Lab Clin Med 1980; 96: 762–9.

    CAS  PubMed  Google Scholar 

  19. Cohen A, Laskin C, Tarlo S. C1 esterase inhibitor in pregnancy. J Allergy Clin Immunol 1992; 90: 412–3.

    Article  CAS  PubMed  Google Scholar 

  20. Cugno M, Castelli R, Cicardi M. Angioedema due to acquired C1-inhibitor deficiency: A bridging condition between autoimmunity and lymphoproliferation. Autoimmun Rev 2008; 8: 156–9.

    Article  CAS  PubMed  Google Scholar 

  21. Simons FE, Ardusso LR, Bilò MB, et al. 2012 Update: World Allergy Organization Guidelines for the assessment and management of anaphylaxis. Curr Opin Allergy Clin Immunol 2012; 12: 389–99.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Laurence Bouillet.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bouillet, L., Boccon-Gibod, I., Berard, F. et al. Recurrent angioedema: diagnosis strategy and biological aspects. Eur J Dermatol 24, 293–296 (2014). https://doi.org/10.1684/ejd.2014.2276

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1684/ejd.2014.2276

Keywords

Navigation